All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

Avanos taps Siemens Healthineers' Americas president as CEO

Avanos taps Siemens Healthineers' Americas president as...

Mar 17, 2025  0

VC firm Sofinnova brings in €1.2B over a year to fund up to 60 life sciences companies

VC firm Sofinnova brings in €1.2B over a year to fund u...

Mar 4, 2025  0

J&J's Monarch bronchoscopy robot cleared by FDA to connect to live CT scans

J&J's Monarch bronchoscopy robot cleared by FDA to conn...

Mar 13, 2025  0